$42.92
Currently 27 wall-street analysts regularly analyze the financials of Ultragenyx Pharmaceutical Inc. on a frequent basis to provide recommendations along with target share price. 27 analysts offering 12-month price forecasts for Ultragenyx Pharmaceutical Inc. (RARE) have a share price target of $90.74. This median of share price forecast represents a 111.41% upside from the latest price of $42.92 as on 06.03.25.
As per the chart shown above, analysts believe that the Ultragenyx Pharmaceutical Inc. (RARE) share price will touch around $90.74 in next 12-months.
Below is a chart showing the percentage difference between Ultragenyx Pharmaceutical Inc.'s share price and its median forecast price. As on 06.03.25, the difference is -44.83%
Based on 27 analysts tracking and researching Ultragenyx Pharmaceutical Inc. (RARE) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 14 | 14 | 15 |
Outperform | 9 | 9 | 9 |
Hold | 3 | 3 | 3 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |